FDA Clearance Tracker · P850064-S056
LifePulse® High Frequency Ventilator
Last checked: Nov 20, 2026Latest source record: Sep 28, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 28, 2026
Approved
Time to decision
537 days
Received Apr 9, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P850064-S056
- Device name
- LifePulse® High Frequency Ventilator
- Applicant
- Bunnell, Inc.
- Applicant location
- Salt Lake City, UT
- Received
- Apr 9, 2025
- Decided
- Sep 28, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P850064
Device type
- Device type
- VENTILATOR, HIGH FREQUENCY (LSZ)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your premarket approval application (PMA) 180-day supplement, which requested approval for an update to the Indications for Use (IFU). The approved updated IFU will read: The LifePulse High Frequency Ventilator is indicated for treating pediatric patients (including neonates) who require temporary ventilatory support for acute respiratory failure. It is the responsibility of the clinician to determine the appropriate use of the LifePulse High Frequency Ventilator. The user needs to consider the respiratory status and the general state of health of the patient in order to optimally set ventilator settings for the patients condition(s).
Source documents
Other decisions for Bunnell, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.